Microfluidic Nested RPA for Rapid Multi-Target Nucleic Acid Detection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing nucleic acid amplification methods are inefficient for rapid, automated detection of trace polynucleotide sequences, particularly for point-of-care testing, and lack the capability to detect multiple targets simultaneously.

Innovation Solution

A microfluidic nucleic acid amplification device with integrated pump modules and interconnected reaction chambers facilitates nested recombinase polymerase amplification (RPA), allowing for selective movement of liquids and multiple rounds of amplification to detect target sequences, using optical or electrochemical detection methods.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Speed

If conventional nucleic acid amplification methods are used, then detection of trace polynucleotide sequences can be achieved, but the process is time-consuming and not suitable for rapid point-of-care testing

Engineering Contradiction:
Improvedetection speedVSAvoidamplification time
Core Design Contradiction:
SpeedVSLoss of time

Solution Approach 1:

The amplification process is divided into two nested rounds: a first round of RPA amplification followed by a second round of amplification on the first round products. This segmentation allows each round to be optimized for specific functions, achieving rapid amplification within 30 minutes while maintaining sensitivity for trace sequence detection

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent implements nested amplification where the second round of amplification targets sequences completely contained within the first round amplification products. This nested structure enables sequential amplification of different target regions, achieving both speed and sensitivity requirements for point-of-care diagnostics

Inventive Principle:
Principle #7Nested doll (Nesting)

2Adaptability or versatility

If conventional amplification methods are used, then single target detection can be performed, but the capability to detect multiple targets simultaneously is lacking

Engineering Contradiction:
Improvemulti-target detection capabilityVSAvoidsystem complexity
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The device is segmented into multiple independent reaction chambers, each capable of performing amplification on different target sequences. This modular segmentation allows simultaneous detection of multiple targets (e.g., influenza A and B viruses) while keeping each individual reaction chamber relatively simple in design

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The microfluidic device is designed with universal features including multiple reaction chambers that can simultaneously perform different amplification reactions, integrated pump modules for fluid control, and detection chambers with optical or electrochemical detection capabilities. This multi-functionality enables the single device to detect multiple different targets without requiring separate systems for each target

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Productivity

If manual processing is used, then flexibility in handling samples can be maintained, but automation and efficiency are reduced

Engineering Contradiction:
Improveamplification efficiencyVSAvoidautomation level
Core Design Contradiction:
ProductivityVSExtent of automation

Solution Approach 1:

The patent merges multiple functions into a single integrated microfluidic device: sample processing, reagent mixing, nested amplification reactions, and detection are all combined in one automated system. The integrated pump modules automatically control fluid movement through the device, eliminating manual intervention and achieving high productivity with complete automation

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The microfluidic device is designed to automatically perform all operations including sample aspiration, reagent delivery, amplification reaction control, and product detection without requiring manual handling. The integrated pump modules and detection systems enable the device to serve itself, maximizing automation and productivity

Inventive Principle:
Principle #25Self-service

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables rapid detection of multiple target nucleic acids within minutes, with results produced in 30 minutes or less, enhancing the accessibility and speed of diagnostics for pathogens and genetic diseases.

Implementation Method 1

Certain isothermal nucleic acid amplification methods are able to amplify target polynucleotide sequences from trace levels to very high and detectable levels within a matter of minutes. Such isothermal methods, e.g., Recombinase Polymerase Amplification (RPA)

Methodology Applied
Scientific EffectRecombinase Polymerase Amplification: Enzyme

Implementation Method 2

Detection may be achieved using optical or electrochemical means

Methodology Applied
Scientific EffectOptical detection: Absorption Spectroscopy

Implementation Method 3

Detection may be achieved using optical or electrochemical means

Methodology Applied
Scientific EffectElectrochemical detection: Electrochemiluminescence

Data Source

PatentUS20250382677A1Automated nested recombinase polymerase amplification
Publication Date: 2025.12.18 ABBOTT DIAGNOSTICS SCARBOROUGH INC
  • US20250382677A1 patent drawing
  • US20250382677A1 patent drawing
  • US20250382677A1 patent drawing

AI summary

A flu assay system including a sample module, a microfluidic nucleic acid amplification device, and an analyzer to facilitate fully automated nested recombinase polymerase amplification (RPA) on a sample delivered to the nucleic acid amplification device via the sample module. The assay includes providing a sample to a microfluidic device, and amplifying a target polynucleotide sequence in the sample. Amplifying the target polynucleotide sequence includes performing a first round of amplification on the sample to yield a first amplification product, and performing a second round of amplification on the first amplification product to yield a second amplification product. The second amplification product includes a smaller sequence completely contained within the first amplification product produced during the first round of amplification.